182 - Psychedelics & Recreational Drugs
- Guest
- David Nutt
- Read time
- ~4 min
- Uploaded
- 1 Nov 2021
- Duration
- 1:40:34
- Views
- 18.4K
KEYPOINTS
- 01
Drug harms can be scored on 16 dimensions.
Nutt, professor of neuropsychopharmacology at Imperial College London, began working on principles for assessing drug harms in the 1990s and advised the UK government from 1994. His framework rates nine harms to the user and seven to society. Across Europe, Britain and Australia, the most harmful drug overall is consistently alcohol — chiefly because of harms to others and because about 80% of American and British adults drink.
- 02
Alcohol is uniquely dangerous because it combines acute and chronic toxicity.
Tobacco kills more people, but usually in their 50s and 60s and with purely chronic toxicity; alcohol kills people in their 20s through accidents and acute poisoning too. Nutt says there's no healthy dose of alcohol, though some doses may not rise to meaningful toxicity; Attia notes how easily the line is crossed.
- 03
US politics shaped global drug law.
Nutt says every British drug law until 2016 was made at the behest of the Americans, starting with 1934-era policy, and the UN largely follows US direction. He traces cannabis hostility to Harry Anslinger's efforts to keep his bureau relevant after alcohol prohibition ended — nearly 90 years of disinformation.
- 04
The cannabis research gap leaves basic questions unanswered.
Attia is frustrated he can't tell parents whether a 16-year-old smoking pot will harm brain development. Nutt argues that with tens of millions of users, utility and harms could have been mapped within a few years if research had been permitted.
- 05
Fentanyl is an economic inevitability of supply crackdowns.
When heroin supply was squeezed, Mexican cartels turned to fentanyl, roughly 50 times more potent than heroin and about half the cost to make. Nutt favours studying treatments like ibogaine for opioid addiction, though its cardiac risks make research difficult; Attia notes untreated opioid addiction itself might carry something like 300-per-1,000 mortality.
- 06
Psychedelics may work by disrupting the default mode network.
Nutt's team's thinking is that the psychedelic state profoundly disrupts the brain's default mode network, potentially breaking over-learned habit circuits in addiction and depression and letting people escape rigid patterns.
- 07
LSD research was extensive and largely positive before it was banned.
Synthesized in the late 1930s, LSD was the subject of over 130 NIH-funded grants, about 40,000 patients and 1,000 papers; it appeared safe, didn't cause psychosis, and if anything reduced suicide. Therapeutic 'big trip' doses were around 100–125 micrograms; 25 micrograms was used to lower resistance in psychotherapy, and anything over about 10 micrograms is perceptible.
- 08
The ban may have cost far more lives than it saved.
A modern meta-analysis by two Norwegian researchers of six old US trials of one or two LSD doses for alcoholism found an effect size of about one — twice that of any later treatment. Nutt estimates over 100 million people died prematurely from alcohol in the 50 years since; even 10% helped would be 10 million lives, versus perhaps 2,500 saved by the ban. This is his rough calculation.
- 09
Psychedelics show rapid tolerance.
Take LSD daily and the second dose is far weaker; at some point people stop responding — unlike drugs such as acetaminophen, whose effect stays roughly constant.
- 10
Psilocybin vs. escitalopram for depression.
In Nutt's New England Journal of Medicine trial, all patients received the same psychotherapy; one arm got 25 mg psilocybin (two doses about three weeks apart), the other escitalopram (Lexapro) with a 1 mg psilocybin placebo. It was reported as a negative study on its primary measure; Nutt says it was never powered for non-inferiority, which would need about 150 patients per arm. 25 mg of psilocybin roughly equals 4–5 g of dried mushrooms.
- 11
Ketamine was the first new antidepressant breakthrough in decades.
Couldn't be patented, so esketamine was developed. Depression doses are modest, but recreational users escalate to grams a day.
EXAMPLES
- 01
Bill Wilson and psychedelics
The founder of Alcoholics Anonymous escaped his alcoholism through a psychedelic experience, later tried LSD when legal, and believed it could help many alcoholics.
- 02
Magic mushrooms in Britain
Mushrooms were legal in the UK until 2005, with about a million young people a year using them; that safety record helped persuade regulators to allow Nutt's psilocybin research. About 200 species of mushroom contain psilocybin.
- 03
Len Bias
The University of Maryland star, drafted by the Boston Celtics, died after cocaine use; his death accelerated the US war on drugs. Nutt notes it's unclear how much he used or whether it was laced.
- 04
Wartime methamphetamine
German and Japanese troops used methamphetamine to stay awake and became sleep-deprived, paranoid and hallucinating. Crystal meth is longer-acting and probably more neurotoxic than amphetamine sulfate, pushing the dopamine system to depletion.
- 05
Drunken drownings
Nutt notes that in Britain 20–30 people a year die jumping, usually drunk, from piers and breakwaters — illustrating alcohol's acute harms.
OTHER RELEVANT
- 01
Judge drugs by evidence, not legal status.
Legal alcohol scores as more harmful overall than many scheduled drugs. The conversation keeps the claim tied to named mechanisms, numbers, and caveats so a listener can act or ask better questions without flattening the nuance.
- 02
Avoid cocaine, especially with heart risk.
Nutt doesn't think it's worth the risk; cardiac events can be sudden. The conversation keeps the claim tied to named mechanisms, numbers, and caveats so a listener can act or ask better questions without flattening the nuance.
- 03
Don't self-treat with psychedelics.
Trial results come with careful screening, preparation and psychotherapy; dose and setting matter.
- 04
Ask about newer depression options.
If SSRIs fail or side effects are intolerable, discuss evidence-based alternatives with a psychiatrist.
- 05
Push for better research, not just looser laws.
Nutt and Attia both argue that the biggest loss from prohibition is knowledge: without trials, clinicians cannot answer basic questions about cannabis, MDMA or psychedelics. Supporting well-designed studies — including dose-finding trials and micro-dosing work — is how claims of benefit and harm get settled.